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Abstract
The objective of this study was to examine population-based pre-
valence of walking in the United States among pregnant women.
Objectively measured walking data on 197 pregnant women who
participated in the National Health and Nutrition Examination Sur-
vey  2005–2006  were  analyzed.  In  general,  pregnant  women
showed a level of walking below the recommendation; most walk-
ing was at low-intensity levels. These findings suggest that walk-
ing,  particularly at  higher  intensity than usual,  should be pro-
moted among pregnant women.
Objective
Women with normal pregnancies are recommended to engage in
regular physical activity for maternal health benefits (1). Walking
is a safe, effective, and accessible form of physical activity for
pregnant women (2) and is a primary physical activity choice in
this population (3). Despite its popularity, few attempts have been
made to describe naturally occurring walking in pregnant women.
Therefore, the objective of this study was to examine the preval-
ence of objectively measured walking in pregnant women by us-
ing the most recent population-based accelerometer data from the
National Health and Nutrition Examination Survey, 2005–2006.
Methods
We analyzed data from 197 pregnant women aged 18 to 45 years
whose pregnancy was confirmed by laboratory test in a mobile ex-
am center (MEC) during the National Health and Nutrition Exam-
ination  Survey (NHANES),  2005–2006 (wwwn.cdc.gov/nchs/
nhanes/search/nhanes05_06.aspx) and who had valid data on study
variables, including 1 or more valid days of accelerometer data
(mean,  4.3  days;  standard  error  [SE],  0.2  days)  (4).  During
NHANES 2005–2006, all ambulatory participants who particip-
ated in the MEC exam were eligible to wear the ActiGraph accel-
erometer (model 7164, ActiGraph) on their waist during waking
hours  for  7  consecutive  days.  The  accelerometer  data  were
screened to determine nonwear time, defined as 60 consecutive
minutes of no activity or up to 2 consecutive minutes with activity
counts less than 100. A valid day was defined as having 10 or
more hours of wear time (mean, 13.3 h/d; SE, 0.2 h/d). Step count
data were censored by excluding the steps featuring low intensity
levels (<500 activity counts/min) (4) because the ActiGraph accel-
erometer likely records low-force movements as steps, which are
not comparable to well-accepted pedometer scales (4). The out-
come variables of interest were total steps per day (average total
step counts accumulated during accelerometer wear time across
valid days), aerobic steps per day (average step counts accumu-
lated for ≥10 consecutive minutes during accelerometer wear time
across valid days), and 1-minute peak cadence (highest steps/min
across valid days). In addition, total minutes and steps accumu-
lated across incremental walking intensity levels were examined
by using cadence bands (0, 1–19, 20–39, 40–59, 60–79, 80–99,
100–119, and ≥120 steps/min) (5). Descriptors of each cadence
band were modified from Tudor-Lock et al (4) to reflect the use of
censored step counts data in this study: 0 = nonstepping activities;
1–19 = incidental steps; 20–39 = sporadic steps; 40–59 = purpose-
ful  steps;  60–79  =  slow  walking;  80–99  =  medium  walking;
100–119 = brisk walking; and ≥120 = faster locomotion.
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Outcome variables were summarized and compared across demo-
graphic variables obtained during the NHANES household and
MEC interviews. The walking intensity levels described by ca-
dence bands were compared across the stages (3 trimesters) of
pregnancy. All analyses accounted for complex sampling design
of NHANES by using survey procedures in SAS version 9.4 (SAS
Institute).
Results
On average, pregnant women took 5,245.8 (SE, 260.2) steps per
day, which included 1,515.0 (SE, 189.6) aerobic steps per day and
a peak cadence of  100.9 (SE,  1.5)  steps per  minute (Table 1).
Total steps per day did not vary statistically by demographic vari-
ables with the exception of the stage of pregnancy. Pregnant wo-
men in the first trimester showed significantly higher mean total
steps per day (mean, 5,586.8 steps/d; SE, 339.5 steps/d) compared
with pregnant women in the third trimester (mean, 4,489.6 steps/d;
SE, 308.1 steps/d). Pregnant women in the third trimester also
showed significantly lower 1-minute peak cadence (mean, 94.9
steps/min; SE, 1.4 steps/min) compared with those in the first tri-
mester (mean, 104.9 steps/min; SE, 2.1 steps/min) and second tri-
mester (mean, 103.5 steps/min; SE, 3.1 steps/min).
On average for the total sample, the largest portion of total steps
per  day was accumulated by sporadic walking (mean,  1,583.9
steps/d; SE, 84.3 steps/d), followed by purposeful walking (mean,
1,273.1 steps/d; SE, 55.9 steps/d) (Table 2). There were no re-
markable differences in accumulated cadence patterns by stage of
pregnancy. Although not significant, accumulated total steps per
day tended to decline by stage of pregnancy at cadence levels less
than 80 steps per minute. Pregnant women in the second trimester
tended to have the highest prevalence of walking at cadence levels
at or higher than 80 steps per minute.
Discussion
To the best of our knowledge, this is the first study to describe nat-
urally occurring walking among representative samples of  US
pregnant women. Pregnant women with no complications are re-
commended to engage in at least 150 minutes of moderate-intens-
ity aerobic physical activity per week (approximately 30 minutes
per day on most days of week) (1), which is approximately equi-
valent to 7,000 to 8,000 steps per day (6). As with findings from
previous studies (3,7), however, our findings demonstrated that
pregnant women had low levels of physical activity, an average of
5,281.8 total steps per day, which falls below the recommendation.
Total  volume of  walking and the  highest  level  of  walking at-
tempts (1-min peak cadence) significantly declined as pregnancy
progressed. Furthermore, our findings regarding walking intensit-
ies based on incremental cadence bands showed that pregnant wo-
men preferred to walk at low-intensity levels and rarely engaged in
walking at moderate or vigorous intensity levels (≥100 steps/min)
(6). This finding aligns with that of a previous study showing a
low prevalence  of  vigorous-intensity  physical  activity  among
pregnant women (7).
The decline of physical activity throughout pregnancy may result
from pregnancy-related physical changes. However, given the in-
creased risk of maternal physical complications as pregnancy pro-
gresses (8,9) and the potential health benefits of physical activity
to reduce such risks (10,11), pregnant women should be physic-
ally active during pregnancy. Furthermore, given recent findings
showing the beneficial association of intensity of walking pace
with health outcomes (eg, reduced risk of gestational diabetes mel-
litus) (12), pregnant women should be encouraged to engage in
more walking activities and at higher intensity levels than usual.
Limitations to our study are the use of cross-sectional data and the
validity of the waist-worn ActiGraph accelerometer to measure
steps in pregnant women. Despite such limitations, our findings
contributed additional information to the existing literature by fo-
cusing on objectively measured walking among a nationally rep-
resentative sample of  US pregnant  women.  Future  studies  are
needed to examine the longitudinal patterns of walking in preg-
nant women to identify the modifiable influencing factors that can
be addressed when developing future intervention strategies.
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Tables
Table 1. Accelerometer-Based Walking Parameters in Pregnant Women (n = 197)a, NHANES 2005–2006
Characteristic % (SE)
Total Steps/Day, Mean
(SE)b,c
Aerobic Steps/Day,
Mean (SE)b,c,d
1-Minute Peak
Cadence, Mean (SE)b,e
Total — 5,245.8 (260.2) 1,515.0 (189.6) 100.9 (1.5)
Age, y
18–30 79.8 (2.8) 4,855.8 (195.3) 1,136.3 (85.9) 99.9 (1.4)
31–45 20.2 (2.8) 6,810.5 (1,107.4) 3,034.4 (1,054.3) 104.8 (4.5)
Pregnancy trimester
1st 21.4 (5.7) 5,586.8 (339.5)f 1,215.4 (177.9) 104.9 (2.1)g
2nd 44.7 (5.6) 5,698.2 (555.7) 2,005.5 (481.6) 103.5 (3.1)h
3rd 33.9 (6.3) 4,489.6 (308.1) 1,084.7 (161.0) 94.9 (1.4)
Race/ethnicity
Non-Hispanic white 60.4 (5.9) 5,205.8 (250.4) 1,287.2 (166.8) 102.1 (1.8)
Mexican American 20.1 (4.2) 4,752.4 (609.0) 1,545.3 (337.4) 99.3 (1.7)
Other 19.5 (4.2) 5,874.3 (1,067.4) 2,177.0 (1,024.3) 98.8 (2.6)
Education
≤High school diploma 32.9 (4.4) 5,927.7 (434.4) 1,863.0 (405.2) 97.0 (2.3)
>High school diploma 67.1 (4.4) 4,881.8 (344.8) 1,329.2 (177.1) 102.8 (2.1)
Marital status
Married/couple 84.3 (4.3) 5,385.4 (353.1) 1,618.5 (245.0) 101.6 (1.8)
Single or other 15.7 (4.3) 4,526.8 (473.9) 981.6 (387.8) 97.1 (2.6)
Smoking status
Yes 5.2 (1.3) 8,356.2 (2,825.5) 5,149.8 (2,919.9) 99.2 (4.3)
No 94.9 (1.3) 5,065.0 (192.3) 1,303.7 (110.4) 101.0 (1.5)
Family income-to-poverty ratio
Abbreviations: BMI, body mass index; — , not applicable; NHANES, National Health and Nutrition Examination Survey; SE, standard error.
a The final sample represented 53.7% of total women with a positive pregnancy test in the NHANES 2005–2006 (n = 367) (wwwn.cdc.gov/nchs/nhanes/search/
nhanes05_06.aspx) after excluding women who 1) were younger than 18 (n = 16); 2) did not participate in accelerometer data collection (n = 60); 3) did not
provide valid accelerometer data (n = 59); and 4) did not provide valid responses on the stage of pregnancy (n = 30) and other study variables (n = 5). The final
analytic sample was more likely to have higher education levels (P < .001) and less likely to be single (P = .03) and pre-obese (P < .001) than the final sample.
b All values accounted for the complex sampling design of NHANES 2005–2006. The general linear model was used to test group mean differences across the
levels of categorical variables after controlling for accelerometer wear time.
c Least-squares mean step counts adjusted for accelerometer wear time.
d Average step counts accumulated for at least 10 consecutive minutes during accelerometer wear time across valid days.
e The highest steps/min during accelerometer wear time across valid days.
f Significantly different from third trimester (P = .02).
g Significantly different from third trimester (P = .004).
h Significantly different from third trimester (P = .02).
i Significantly different from third tertile (P = .01).
j BMI was calculated by using objectively measured current height (cm) and self-reported weight (kg) 1 year ago was used to determine obesity status (BMI ≥30kg/
m2).
k Self-reported number of deliveries resulting in a live birth was used.
(continued on next page)
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(continued)
Table 1. Accelerometer-Based Walking Parameters in Pregnant Women (n = 197)a, NHANES 2005–2006
Characteristic % (SE)
Total Steps/Day, Mean
(SE)b,c
Aerobic Steps/Day,
Mean (SE)b,c,d
1-Minute Peak
Cadence, Mean (SE)b,e
1st tertile 22.1 (2.6) 5,897.5 (664.0) 2,318.5 (608.1) 97.8 (2.0)
2nd tertile 37.6 (3.9) 5,016.1 (230.5) 865.2 (137.6) 97.7 (1.7)i
3rd tertile 40.4 (3.8) 5,085.3 (392.3) 1,683.2 (212.3) 105.6 (2.7)
Obese (1 year ago)j
Yes (BMI ≥30 kg/m2) 87.0 (4.6) 4,534.7 (349.2) 1,513.5 (190.6) 98.8 (1.4)
No (BMI <30 kg/m2) 13.0 (4.6) 5,341.8 (269.2) 1,526.5 (406.3) 101.2 (1.8)
Previous live birthsk
Yes (≥1 live birth) 57.9 (5.7) 5,492.6 (370.2) 1,285.1 (158.4) 98.4 (2.1)
No (no live birth) 42.1 (5.7) 4,910.9 (250.2) 1,684.4 (403.6) 104.3 (1.7)
Abbreviations: BMI, body mass index; — , not applicable; NHANES, National Health and Nutrition Examination Survey; SE, standard error.
a The final sample represented 53.7% of total women with a positive pregnancy test in the NHANES 2005–2006 (n = 367) (wwwn.cdc.gov/nchs/nhanes/search/
nhanes05_06.aspx) after excluding women who 1) were younger than 18 (n = 16); 2) did not participate in accelerometer data collection (n = 60); 3) did not
provide valid accelerometer data (n = 59); and 4) did not provide valid responses on the stage of pregnancy (n = 30) and other study variables (n = 5). The final
analytic sample was more likely to have higher education levels (P < .001) and less likely to be single (P = .03) and pre-obese (P < .001) than the final sample.
b All values accounted for the complex sampling design of NHANES 2005–2006. The general linear model was used to test group mean differences across the
levels of categorical variables after controlling for accelerometer wear time.
c Least-squares mean step counts adjusted for accelerometer wear time.
d Average step counts accumulated for at least 10 consecutive minutes during accelerometer wear time across valid days.
e The highest steps/min during accelerometer wear time across valid days.
f Significantly different from third trimester (P = .02).
g Significantly different from third trimester (P = .004).
h Significantly different from third trimester (P = .02).
i Significantly different from third tertile (P = .01).
j BMI was calculated by using objectively measured current height (cm) and self-reported weight (kg) 1 year ago was used to determine obesity status (BMI ≥30kg/
m2).
k Self-reported number of deliveries resulting in a live birth was used.
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Table 2. Accumulated Time and Steps per Day in Cadence Bands by Stage of Pregnancy (n = 197)a
Time and Steps
Cadence Band (Steps/Min)b
0 1–19 20–39 40–59 60–79 80–99 100–119 ≥120
Minutes/d
Total (SE) 646.2(4.6) 36.0 (2.0) 54.4 (2.9) 26.6 (1.2) 10.0 (0.3) 5.9 (0.4) 6.2 (2.2) 0.7 (0.5)
% (SE) 82.2 (0.6) 4.6 (0.3) 6.9 (0.4) 3.4 (0.2) 1.3 (0.1) 0.8 (0.1) 0.9 (0.3) 0.1 (0.1)
1st Trimester 635.2 (13.5) 41.2 (4.5) 56.0 (7.2) 28.4 (3.1) 12.0 (0.6) 6.4 (0.8) 6.6 (1.6) 0.2 (0.1)
% (SE) 80.6 (1.6) 5.1 (0.6) 7.3 (0.9) 3.7 (0.4) 1.5 (0.1) 0.8 (0.1) 0.9 (0.2) 0.02 (0.01)
2nd Trimester 644.1 (6.4) 34.8 (4.0) 52.8 (1.9) 27.1 (1.6) 10.1 (0.7) 6.6 (0.7) 9.0 (4.4) 1.4 (0.9)
% (SE) 82.0 (0.9) 4.6 (0.4) 6.6 (0.2) 3.4 (0.2) 1.3 (0.1) 0.8 (0.1) 1.3 (0.7) 0.2 (0.13)
3rd Trimester 655.2 (11.4) 34.6 (2.8) 55.3 (7.3) 25.0 (2.1) 8.6 (0.6) 4.7 (0.6) 2.4 (0.9) 0.1 (0.04)
% (SE) 83.5 (1.4) 4.2 (0.3) 7.0 (0.9) 3.2 (0.3) 1.1 (0.1) 0.6 (0.1) 0.3 (0.2) 0.01 (0.01)
P valuec .50 .46 .80 .55 .005 .06 .16 .43
Steps/d
Total — 428.3 (23.9) 1,583.9
(84.3)
1,273.1 (55.9) 683.5 (18.9) 525.1 (39.8) 661.9
(236.0)
90.2 (59.3)
% (SE) — 9.3 (0.5) 32.7 (1.0) 25.3 (0.9) 13.4 (0.4) 9.5 (0.5) 8.5 (1.3) 1.3 (0.8)
1st Trimester — 479.0 (58.8) 1,623.7
(204.6)
1,355.9
(148.4)
823.7 (40.6) 574.1 (74.3) 711.4
(171.6)
19.1 (9.3)
% (SE) — 9.8 (0.8) 31.2 (1.4) 25.0 (0.8) 15.0 (0.9) 9.7 (0.8) 9.0 (1.7) 0.3 (0.1)
2nd Trimester — 412.7 (40.3) 1,549.6
(59.1)
1,296.3 (75.2) 693.2 (47.6) 591.8 (72.8) 966.7
(468.7)
187.8 (130.8)
% (SE) — 9.2 (1.0) 31.4 (1.7) 24.9 (1.5) 12.5 (0.5) 9.4 (0.7) 9.9 (2.2) 2.7 (1.7)
3rd Trimester — 417.9 (42.2) 1,603.0
(206.4)
1,196.2
(102.8)
589.8 (38.2) 414.3 (54.2) 257.3
(105.4)
11.1 (4.5)
% (SE) — 9.2 (0.5) 35.2 (1.6) 26.0 (0.8) 13.5 (0.9) 9.6 (0.9) 6.4 (1.0) 0.2 (0.1)
P valuec — .57 .87 .55 .004 .06 .16 .43
Abbreviations: SE, standard error; —, not applicable.
a All values are presented as mean (SE) after accounting for complex sampling design of National Health and Nutrition Examination Survey 2005–2006
(wwwn.cdc.gov/nchs/nhanes/search/nhanes05_06.aspx) and were estimated using the censored minute-by-minute step counts data adjusted for accelerometer
wear time.
b Descriptors of each cadence band were modified from Tudor-Lock et al (4) to reflect the use of censored step counts data in this study: 0 = nonstepping activit-
ies; 1–19 = incidental steps; 20–39 = sporadic steps; 40–59 = purposeful steps; 60–79 = slow walking; 80–99 = medium walking; 100–119 = brisk walking; and
≥120 = faster locomotion.
c P values were estimated for main group effects from general linear models after controlling for accelerometer wear time.
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